2016 International Congress

Thursday, June 23, 2016

12:00pm-1:30pm

Activities of daily living and motor scores of the UPDRS in fluctuating Parkinson’s disease patients treated with opicapone

J. Ferreira, A. Lees, O. Rascol, T. Müller, A. Santos, I. Oliveira, N. Lopes, J.F. Rocha, P. Soares-da-Silva (Lisbon, Portugal)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Acute admissions in people with Parkinson’s – More than just frailty

N. Leopold, B. Mohamed, C. Thomas (Cardiff, United Kingdom)

Parkinson's Disease: Clinical Trials II and Non-PD Clinical Trials

12:00pm-1:30pm

Acute movement disorders in Tunisian childhood

H. Benrhouma, H. Klaa, A. Nasri, I. Kraoua, I. Turki (Tunis, Tunisia)

Pediatric movement disorder  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

ADCY5 screening in paediatric-onset hyperkinetic movement disorders: Report of three new Italian families

M. Carecchio, N.E. Mencacci, G. Zorzi, F. Zibordi, C. Fusco, A. Iodice, L. Veneziano, C. Barzaghi, L. 'RBibo, N. Wood, B. Garavaglia, N. Nardocci (Milan, Italy)

Dystonia and Pediatric Movement Disorders

12:00pm-1:30pm

Adenosine A2A receptor antagonist istradefylline might have efficacy to fatigue and depression in some patients of Parkinson’s disease

H. Ito, T. Kamei (Fujisawa, Japan)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

ADS-5102 (amantadine HCl) extended-release capsules reduced levodopa-induced dyskinesia in the phase 3 EASE LID study

R. Pahwa, C.M. Tanner, R.A. Hauser, P. Nausieda, D.D. Truong, K. Hull, P. Agarwal, R. Johnson, A.E. Ruby, N.L. McClure, M.J. Stempien (Kansas City, KS, USA)

Pharmacology

12:00pm-1:30pm

Adult onset Niemann-Pick type C: 24 month follow-up on miglustat

B. Elibol, F. Ozkinay, H. Onder (Ankara, Turkey)

Other  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Altered inter-hemispheric functional coordination in primary blepharospasm

J. Yang, C. Luo, W. Song, Q. Wei, R. Ou, Y. Hou, Q. Gong, H. Shang (Chengdu, People's Republic of China)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Alternating hemiplegia of childhood: Movement disorders and epilepsy due to mutuations in ATP1A3

A.P. Kleinert-Altamirano, M.O. Fiesco-Roa, K. Brockmann, E. Liebermann-Hernández, C. Marques-Lourenco (Tuxtla Gutiérrez, Mexico)

Pediatric movement disorder  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Amelioration of αLPHA-synuclein aggregation and motor behavior deficits by apocyanin in intranigral lipopolysaccharide induced animal model of Parkinson’s disease

B. Nehru, N. Sharma (Chandigarh, India)

Neuropharmacology  ·  Exhibit Hall located in Hall B, Level 2